Skip to main content
. Author manuscript; available in PMC: 2011 Nov 10.
Published in final edited form as: Vaccine. 2010 Sep 25;28(48):7659–7666. doi: 10.1016/j.vaccine.2010.09.040

Table 3.

CD4+ T-cell responses of immunized mice the day before the i.n. challenge with C. trachomatis MoPna

Groups CD4+ cell proliferative response to EBb (103 × Δcpm) In vitro cytokine production in response to EB (pg/ml)
IFN-γ IL-4
rMOMP- s.l. 4.6 ± 2.1c 73 ± 2c,d < 4
rMOMP- s.l.+i.m.+s.c. 7.6 ± 2.2c 93 ± 0c,e,f,g < 4
rMOMP- c.l. 8.5 ± 3.8c 48 ± 1c < 4
rMOMP- c.l.+i.m.+s.c. 5.8 ± 3.1c 78 ± 6c,i < 4
rMOMP- i.m.+s.c. 10.8 ± 6.1c 83 ± 2c < 4
Ng-rPorB- i.m.+s.c. 1.6 ± 0.5 < 31 < 4
MoPn- i.n. 18.7 ± 5.5c 1,659 ± 110c < 4
a

Values are mean ± 1SD.

b

C. trachomatis MoPn EB were added at a ratio of EB : APC+CD4+ cells of 1:5.

c

P < 0.05 by the Student’s t test in comparison with Ng-rPorB immunized group.

d

P <0.05 by the Student’s t test by comparing rMOMP- s.l. group with rMOMP- c.l. group.

e

P <0.05 by the Student’s t test by comparing rMOMP- s.l.+i.m.+s.c. group with rMOMP- i.m.+s.c. group.

f

P < 0.05 by the Student’s t test by comparing rMOMP- s.l.+i.m.+s.c. group with rMOMP- s.l. group.

g

P <0.05 by the Student’s t test by comparing rMOMP- s.l.+i.m.+s.c. group with rMOMP- c.l.+i.m.+s.c. group.

h

P < 0.05 by the Student’s t test by comparing rMOMP- c.l.+i.m.+s.c. group with rMOMP- c.l. group.